# Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI

Study · id `cardio:ct-nct07641231` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07641231](<https://clinicaltrials.gov/study/NCT07641231>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07641231

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 240 participants.

## Technical summary

Registry record NCT07641231. Randomized; no masking; primary purpose treatment. Start 2026-05-20 (anticipated); primary completion 2028-05-20 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT07641231, source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)
- Planned start: 2026-05-20 (anticipated) (ClinicalTrials.gov record NCT07641231, source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)
- Primary completion: 2028-05-20 (anticipated) (ClinicalTrials.gov record NCT07641231, source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)
- Completion: 2029-05-20 (anticipated) (ClinicalTrials.gov record NCT07641231, source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT07641231, source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07641231-2026-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI
- Acronym: RAPID-STEMI
- Condition: STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug): Single, weight-adjusted i.v. bolus of tenecteplase
- Intervention (Procedure): catheterisation
- Lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Lead sponsor class: OTHER\_GOV
- Collaborator: AO GENERIUM
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (`cardio:org-national-medical-research-center-for-cardiology-ministry-of-62fee0`)
- Registry lists this organization as a collaborator: AO GENERIUM (`cardio:org-ao-generium`)

## Provenance

Content hash: 57d2601f64080d3efde483b17d59fafd0a78cf005e9ea3ba000b276fe11fd8ac
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
